Evidence map›Paper›PMID 27262355›Full record

ArticleInfection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases2016

The global spread of HIV-1 subtype B epidemic.

Gkikas Magiorkinis, Konstantinos Angelis, Ioannis Mamais, Aris Katzourakis, Angelos Hatzakis, Jan Albert, Glenn Lawyer, Osamah Hamouda, Daniel Struck, Jurgen Vercauteren and 40 more

Abstract read
In one paragraph

Article in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Historical and theoretical roots of the big events framework.The International journal on drug policy · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Residues TRetrovirology · 2021
    Article
  13. HIV in pregnancy - An update.European journal of obstetrics, gynecology, and reproductive biology · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

50 authors.

Gkikas MagiorkinisDepartment of Zoology, University of Oxford, United Kingdom. Electronic address: gkikas.magiorkinis@zoo.ox.ac.uk.
Konstantinos AngelisDepartment of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Greece.
Ioannis MamaisDepartment of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Greece.
Aris KatzourakisDepartment of Zoology, University of Oxford, United Kingdom.
Angelos HatzakisDepartment of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Greece.
Jan AlbertDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Glenn LawyerDepartment of Computational Biology, Max Planck Institute for Informatics, Saarbrücken, Germany.
Osamah HamoudaRobert Koch-Institute, Berlin, Germany.
Daniel StruckCentre de Recherche Public de la Sante, Luxembourg, Luxembourg.
Jurgen VercauterenClinical and Epidemiological Virology, Rega Institute for Medical Research, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
Annemarie WensingDepartment of Virology, University Medical Center, Utrecht, The Netherlands.
Ivailo AlexievNational Center of Infectious and Parasitic Diseases, Sofia, Bulgaria.
Birgitta ÅsjöUniversity of Bergen, Bergen, Norway.
Claudia BalottaUniversity of Milan, Milan, Italy.
Perpétua GomesMolecular Biology Lab, LMCBM, SPC, HEM, Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal.
Ricardo J CamachoClinical and Epidemiological Virology, Rega Institute for Medical Research, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
Suzie CoughlanUniversity College Dublin, Dublin, Ireland.
Algirdas GriskeviciusLithuanian AIDS Center, Vilnius, Lithuania.
Zehava GrossmanTel Aviv University, Tel Aviv, Israel.
Anders HorbanHospital of Infectious Diseases, Warsaw, Poland.
Leondios G KostrikisUniversity of Cyprus, Nicosia, Cyprus.
Snjezana J LepejDepartment of Molecular Diagnostics and Flow Cytometry, University Hospital for Infectious Diseases "Dr. F. Mihaljevic", Zagreb, Croatia.
Kirsi LiitsolaNational Institute of Health and Welfare, Helsinki, Finland.
Marek LinkaNational Reference Laboratory of AIDS, National Institute of Health, Prague, Czech Republic.
Claus NielsenStatens Serum Institute, Copenhagen, Denmark.
Dan OteleaNational Institute for Infectious Diseases "Prof. Dr. Matei Bals", Bucharest, Romania.
Roger ParedesIrsiCaixa Foundation, Badalona, Spain.
Mario PoljakSlovenian HIV/AIDS Reference Centre, University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia.
Elizabeth Puchhammer-StöcklUniversity of Vienna, Vienna, Austria.
Jean Claude SchmitCentre de Recherche Public de la Sante, Luxembourg, Luxembourg.
Anders SönnerborgDepartment of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden; Divisions of Infectious Diseases and Clinical Virology, Karolinska Institute, Stockholm, Sweden.
Danica StanekováSlovak Medical University, Bratislava, Slovakia.
Maja StanojevicUniversity of Belgrade Faculty of Medicine, Belgrade, Serbia.
Dora C StylianouUniversity of Cyprus, Nicosia, Cyprus.
Charles A B BoucherErasmus MC, University Medical Center, Rotterdam, The Netherlands.
SPREAD program
Georgios NikolopoulosDepartment of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Greece.
Tetyana VasylyevaDepartment of Zoology, University of Oxford, United Kingdom.
Samuel R FriedmanInstitute of Infectious Diseases Research, National Development and Research Institutes, Inc., New York, USA.
David van de VijverEijkman Winkler Institute, Department of Virology, University Medical Center Utrecht, Utrecht, The Netherlands.
Gioacchino AngaranoUniversity of Foggia, Foggia, Italy.
Marie-Laure ChaixLaboratoire de Virology, Hôpital Necker Paris, France.
Andrea de LucaInstitute of Clinical Infectious Diseases, Catholic university, Rome, Italy.
Klaus KornUniversity of Erlangen, Erlangen, Germany.
Clive LovedayInternational Clinical Virology Centre, Buckinghamshire, England, United Kingdom.
Vincent SorianoHospital Carlos III, Madrid, Spain.
Sabine YerlyGeneva University Hospital, Geneva, Switzerland.
Mauricio ZazziUniversity of Siena, Siena, Italy.
Anne-Mieke VandammeClinical and Epidemiological Virology, Rega Institute for Medical Research, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
Dimitrios ParaskevisDepartment of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Greece. Electronic address: dparask@med.uoa.gr.

Funding

Preventing HIV Transmission by Recently-Infected Drug UsersDP1DA034989 · NIDA · NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC. · PI FRIEDMAN, SAMUEL R · 2012 to 2016
$3.8M
Medical Research Council MR/K010565/1NIDA NIH HHS DP1 DA034989
6 · The paper itself

Abstract

Human immunodeficiency virus type 1 (HIV-1) was discovered in the early 1980s when the virus had already established a pandemic. For at least three decades the epidemic in the Western World has been dominated by subtype B infections, as part of a sub-epidemic that traveled from Africa through Haiti to United States. However, the pattern of the subsequent spread still remains poorly understood. Here we analyze a large dataset of globally representative HIV-1 subtype B strains to map their spread around the world over the last 50years and describe significant spread patterns. We show that subtype B travelled from North America to Western Europe in different occasions, while Central/Eastern Europe remained isolated for the most part of the early epidemic. Looking with more detail in European countries we see that the United Kingdom, France and Switzerland exchanged viral isolates with non-European countries than with European ones. The observed pattern is likely to mirror geopolitical landmarks in the post-World War II era, namely the rise and the fall of the Iron Curtain and the European colonialism. In conclusion, HIV-1 spread through specific migration routes which are consistent with geopolitical factors that affected human activities during the last 50years, such as migration, tourism and trade. Our findings support the argument that epidemic control policies should be global and incorporate political and socioeconomic factors.

Indexed as

HIV-1Cluster AnalysisEpidemicsHIV InfectionsHuman ActivitiesHumansPhylogeographyHIV-1MigrationMigration patternPhylogeographySubtype B

Identifiers

PMID27262355
PMCPMC5157885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.